Search results
Results from the WOW.Com Content Network
Lawreen Marie Heller Connors (August 9, 1954 – October 20, 2024) was an American biochemist, medical researcher, and college professor. She was a professor of pathology and laboratory medicine at Boston University School of Medicine from 1998 until she retired in 2022. Her research focused on the protein amyloid, and the related disease ...
Boston City Hospital was the first municipal hospital in the United States, opening in 1864. [4]In 1960 Boston University's Medical School founded the Boston University Medical Center in the South End neighborhood to provide residency programs and research opportunities for students and faculty.
The Boston criteria version 2.0 [1] is a set of guidelines designed to diagnose cerebral amyloid angiopathy (CAA), a disease that affects small blood vessels in the brain, particularly those in the cortex and leptomeninges. Although the gold standard for diagnosis is histopathological examination, the Boston criteria provide clinicians with a ...
Wild-type transthyretin amyloid (WTTA), also known as senile systemic amyloidosis (SSA), [1] is a disease that typically affects the heart and tendons of elderly people. It is caused by the accumulation of a wild-type (that is to say a normal ) protein called transthyretin .
AA amyloidosis is a form of amyloidosis, a disease characterized by the abnormal deposition of fibers of insoluble protein in the extracellular space of various tissues and organs. In AA amyloidosis, the deposited protein is serum amyloid A protein (SAA), an acute-phase protein which is normally soluble and whose plasma concentration is highest ...
AL amyloidosis is a rare disease; only 1200 to 3200 new cases are reported each year in the United States, and between 500 and 600 in the UK. Two thirds of patients with AL amyloidosis are male and less than 5% of patients are under 40 years of age. [6] [19] [9]
The Boston University Medical Campus (BUMC) is one of the three campuses of Boston University, the others being the Charles River Campus and the Fenway Campus. The campus is situated in the South End neighborhood of Boston , Massachusetts , United States .
Aducanumab, sold under the brand name Aduhelm, is a monoclonal antibody designed to treat Alzheimer's disease. It is a monoclonal antibody that targets aggregated forms (plaque) of amyloid beta (Aβ) found in the brains of people with Alzheimer's disease to reduce its buildup. [10] It was developed by Biogen and Eisai. [11] Aducanumab is given via intravenous infusion. [5] Aducanumab was ...